A ResMed insider sale on October 23, 2026, reduced Global General Counsel Michael Rider’s holding by 400 shares, leaving him with 12,318 shares. The transaction represents a small reduction in his investment rather than an exit from the medical-device company.

Key Takeaways

  • Rider retained 12,318 shares after the reported sale.
  • The available transaction details do not establish the execution price or reason for selling.
  • A separate SEC Form 144 record concerns a proposed sale, not confirmation of execution.

ResMed insider sale leaves most of Rider’s holding intact

Rider’s reported sales over the preceding year totaled 550 shares, with no purchases recorded during that period. The October transaction therefore accounted for most of his reported share disposals over that timeframe.

ResMed shares traded at $255 on the transaction date. That market quotation is not an established execution price for Rider’s sale and does not confirm the proceeds he received.

ResMed, listed on the New York Stock Exchange under the symbol RMD, makes devices and software for sleep apnea and other respiratory conditions. Its products include continuous positive airway pressure machines, masks and remote therapy-monitoring tools.

Proposed-sale notice is distinct from execution disclosure

The SEC’s October 23 proposed-sale filing record identifies ResMed as the subject company and Michael J. Rider as the reporting person. It is a Form 144 notice, distinct from the Form 4 ownership disclosure cited for the completed transaction.

That filing-detail page does not independently establish the completed 400-share sale, its execution price or the remaining 12,318-share holding. The available transaction details also do not explain Rider’s motivation, so the sale alone does not establish a change in his assessment of ResMed’s prospects.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.